Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ: EVO )

4.950 +0.090 (+1.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 31,358
Open 4.890
Bid (Size) 4.760 (1)
Ask (Size) 5.000 (5)
Prev. Close 4.860
Today's Range 4.890 - 4.960
52wk Range 3.940 - 13.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Via ACCESSWIRE
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover. 
Via Benzinga

Performance

YTD
-56.58%
-56.58%
1 Month
-0.40%
-0.40%
3 Month
-35.12%
-35.12%
6 Month
-56.58%
-56.58%
1 Year
-55.37%
-55.37%

More News

Read More
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Evotec Reports Q1 2024 Results and Provides Corporate Update
Via ACCESSWIRE
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Via ACCESSWIRE
Evotec SE: Results of the Annual General Meeting 2024
Via ACCESSWIRE
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
Via ACCESSWIRE
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
Via ACCESSWIRE
EVO Stock Earnings: Evotec Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024
Via ACCESSWIRE
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
From Centogene NV
Via GlobeNewswire
3 Growth Stocks to Buy at 52-Week Lows
Via InvestorPlace
Bayer and Evotec Collaborate to Advance Precision Cardiology
Via ACCESSWIRE
Crude Oil Moves Lower; B. Riley Financial Shares Jump
Via Benzinga
Exposures Fossil Fuels
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
Via Benzinga
Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast
Via Benzinga
Why Is Fabrinet (FN) Stock Down Today?
Via InvestorPlace
Why Is Evotec (EVO) Stock Down 33% Today?
Via InvestorPlace
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.